Saltar al contenido
Merck

The role of mitochondrial bioenergetics and oxidative stress in depressive behavior in recurrent concussion model in mice.

Life sciences (2020-06-23)
Leandro Severo, Douglas Godinho, Felipe Machado, Diane Hartmann, Michele Rechia Fighera, Félix Alexandre Soares, Ana Flavia Furian, Mauro Schneider Oliveira, Luiz Fernando Royes
RESUMEN

Traumatic brain injury (TBI) is a public health problem in which even though 80 to 90% of cases are considered mild, usually starts a sequence of neurological disorders that can last a considerable time. Most of the research of this injury has been focused on oxidative stress and functional deficits; however, mechanisms that underlie the development of neuropsychiatric disorders remain little researched. Due to this, the present authors decided to investigate whether recurrent concussion protocols alter depressive-like phenotype behavior, and whether mitochondria play an indispensable role in this behavior or not. The experimental data revealed, for the first time, that the present protocol of recurrent concussions (4, 7, and 10 injuries) in mice did not alter immobility time during tail suspension tests (TSTs), but decreased hippocampal mitochondrial respiration and increased expression of proteins such as nuclear factor erythroid 2-related factor 2 (Nrf2) and superoxide (SOD2). This experimental data suggests that bioenergetic changes elicited by recurrent concussion did not induce depressive-like behavior, but activated the transcription factor of responsive antioxidant elements (ARE) that delay or prevent secondary cascades in this neurological disease.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Seroalbúmina bovina, heat shock fraction, pH 7, ≥98%
Sigma-Aldrich
Cloruro de sodio, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
Piruvato sódico, ReagentPlus®, ≥99%
Sigma-Aldrich
Ponceau S solution, BioReagent, suitable (for use in cellulose acetate electrophoresis), 0.1 % (w/v) in 5% acetic acid
Sigma-Aldrich
Carbonyl cyanide 3-chlorophenylhydrazone, ≥97% (TLC), powder
Sigma-Aldrich
L-Glutamic acid monosodium salt hydrate, ≥99% (HPLC), powder
Sigma-Aldrich
Fosfato de potasio monobasic, Molecular Biology, ≥98.0%
Sigma-Aldrich
Sodium succinate dibasic hexahydrate, ReagentPlus®, ≥99%
Sigma-Aldrich
L-(−)-Malic acid, ≥95% (titration)
Sigma-Aldrich
(−)-Epinephrine (+)-bitartrate salt, solid